Newsroom | 9829 results
Sorted by: Latest
-
Molina Healthcare of Florida Announces a $70,000 Grant Funding NAMI’s Behavioral Health Peer Mentor Program
MIAMI--(BUSINESS WIRE)--Molina Healthcare of Florida announces a $70,000 grant funding NAMI’s behavioral health peer mentor program....
-
Definium Therapeutics to Participate at Upcoming Investor Conferences
NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.), (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that members of the Company’s management team will participate in the following investor conferences: TD Cowen 46th Annual Health Care Conference Presentation Date and Time: Monday, March 2, 2026 at...
-
Compass Pathways to attend TD Cowen 46th Annual Healthcare Conference in Boston, MA from March 2-4, 2026
LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the TD Cowen 46th Annual Healthcare Conference in Boston, MA, from March 2-4, 2026 and will participate in a fireside chat on March 3, 2026 at 10:30am ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compas...
-
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at three upcoming investor conferences: TD Cowen's 46th Annual Health Care Conference Fireside Chat: Monday, March 2, 2026 at 11:10 a.m. Eastern Time in Boston, MA The Citizens Life Sciences Conference Fireside Chat: Wednesday, March 11, 2026 at 1:05 p.m. Eastern Time in Miami Beach, FL Live webcasts will be accessible on the company’s website, acadia.com, under the investors section...
-
Bradford Health Services Announces Expansion Into Midwest With Acquisition of Parkdale Center, Expanding Specialized Treatment for Professionals
BIRMINGHAM, Ala.--(BUSINESS WIRE)--Bradford Health Services (Bradford), a nationally recognized substance use disorder treatment provider, today announced the acquisition of Parkdale Center, a leading addiction treatment provider in Chesterton, Indiana. Parkdale Center is widely renowned for its specialized Professionals Program serving healthcare providers, attorneys, executives, aviation professionals, first responders, and other licensed professionals seeking confidential treatment and long-...
-
Serenity Mental Health Centers Expands Mental Health Services in Dallas
DALLAS--(BUSINESS WIRE)--Serenity Mental Health Centers, a leader in psychiatric care and one of the fastest growing mental health providers in the nation, is elevating mental health services in Dallas by providing advanced, patient-centered treatment options at its clinics in Frisco, Las Colinas, Fort Worth, Southlake, Arlington, and University Park. Serenity’s board-certified psychiatrists and psychiatric mental health nurse practitioners provide full-spectrum mental health services tailored...
-
Acadia Healthcare to Participate in March Investor Conferences
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in three investor conferences in March. On Monday, March 2, 2026, the Company will participate in the Raymond James & Associates’ 47th Annual Institutional Investors Conference, being held March 1-4, 2026, in Orlando, Florida. The Company’s presentation/fireside chat will begin at 11:35 a.m. Eastern Time/10:35 a.m. Central Time. On Monday, March 9, 2026, the Com...
-
Seaport Therapeutics Presents New Meta-Analysis Examining the Impact of Clinical Trial Design Factors on Placebo Response in Generalized Anxiety Disorder Trials
BOSTON--(BUSINESS WIRE)--Seaport presents new meta-analysis examining the impact of clinical trial design factors on placebo response in generalized anxiety disorder trials...
-
Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026
NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.), (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that it will host a live webcast at 4:30 p.m. EST on Thursday, February 26, 2026 to report financial results for the full year ended December 31, 2025, and discuss recent business updates. Listeners...
-
Groundbreaking Clinical Study Reveals Promising Evidence for VIVAZEN®’s Kratom Extracts
PHOENIX--(BUSINESS WIRE)--VIVAZEN® proudly announces the results of a pioneering 28-day clinical study evaluating the safety and tolerability of its proprietary kratom extracts. The findings, presented by Dr. Jenelle Patterson of Gowling WLG, at the University of Florida Fifth Scientific Kratom Symposium, reinforce VIVAZEN®’s dedication to advancing knowledge in botanical wellness through rigorous scientific research. The study assessed the effects of VIVAZEN®’s proprietary kratom extract on ad...